-
Honokiol (N1672) for Reliable Cell Assays
2026-09-04
This scenario-driven guide explains how Honokiol (SKU N1672) can be incorporated into cell viability, proliferation, cytotoxicity, inflammation, and cancer research workflows. It addresses solvent compatibility, assay interference, dose–time design, mechanistic interpretation, and practical product-selection criteria using documented specifications and a recent immunometabolism study.
-
FLCN Mutations and mRNA Rescue in BHD Syndrome
2026-09-04
A 2026 study identified a novel FLCN nonsense variant and provided genetic and functional evidence that p.W376R is pathogenic in two Chinese Birt-Hogg-Dubé families. In HEK293T cells, synthetic FLCN mRNA restored folliculin expression and reduced abnormal mTORC1 activation, offering an early in vitro rationale for mRNA-based protein replacement.
-
SZQ-3 Targets NF-κB in Postmenopausal Osteoporosis
2026-09-03
The reference study identifies SZQ-3, a chromone–maleimide hybrid, as a dual-action candidate that protects osteoblasts and suppresses osteoclast differentiation through NF-κB and mitochondrial regulation. Its combination of cell models, transcriptomics, molecular docking, and an ovariectomy-induced mouse model provides a mechanistic framework for evaluating safer treatments for postmenopausal osteoporosis.
-
Sorafenib Workflows for Liver Cancer Research
2026-09-03
Build more informative liver cancer experiments with Sorafenib (BAY-43-9006), from DMSO stock preparation and dose-response testing to RAF/MEK/ERK, VEGFR, angiogenesis, and mitochondrial readouts. The workflow also shows how to use Sorafenib as a mechanistic comparator for emerging cholesterol-driven mitophagy research.
-
Paclitaxel (Taxol): Reliable Cell Assays
2026-09-02
Learn how Paclitaxel (Taxol), SKU A4393, can improve dose-response design, solvent control, and interpretation in cell viability and proliferation assays. This scenario-based guide connects product data with practical cancer research workflows while highlighting limitations that affect reproducibility.
-
Amyloid β-Peptide (1-42): State Shapes Signal
2026-09-02
Amyloid β-Peptide (1-42) is more than a neurotoxic stimulus: its aggregation state, exposure history, and assay context shape the observed biology. This guide connects Aβ42 peptide chemistry with neuronal, ion-channel, and microglial readouts for more interpretable Alzheimer’s disease research.
-
Paclitaxel (Taxol) Workflows for Cancer Research
2026-09-01
Paclitaxel (Taxol) converts microtubule stabilization into measurable cell-cycle, mitotic, and apoptosis endpoints. This practical workflow helps cancer research teams optimize dosing, validate phenotypes, and evaluate paclitaxel combinations in breast cancer models without overinterpreting model-specific results.
-
Human Intestinal Organoids for Pharmacokinetic Studies
2026-09-01
Saito and colleagues developed a direct three-dimensional cluster-culture method for generating expandable intestinal organoids from human induced pluripotent stem cells. The resulting organoids could be propagated, cryopreserved, and converted into intestinal epithelial monolayers containing metabolically and transport-competent enterocytes, providing a more human-relevant platform for oral drug pharmacokinetic studies.
-
Synthetic OLIG2 mRNA Drives Rapid hiPSC Differentiation
2026-08-31
The reference study presents a transgene-free strategy for converting human induced pluripotent stem cells into oligodendrocyte progenitor cells by repeatedly delivering synthetic modified messenger RNA encoding OLIG2S147A. Its rapid differentiation schedule, progenitor-cell yield, and subsequent functional remyelination findings make the work relevant to regenerative neuroscience and mRNA-based cellular engineering.
-
Lactate–Ran Lactylation Drives Astrocyte Polarization
2026-08-31
A 2026 study identifies Ran lactylation at lysine 123 as a non-histone mechanism linking lactate accumulation to STAT3 nuclear transport and A2 astrocyte polarization after oxygen-glucose deprivation/reoxygenation. The findings position SIRT1-regulated Ran lactylation as a mechanistic connection between metabolism and cellular responses to spinal cord injury, while also defining experimental entry points for studying this pathway.
-
Cy3 NHS ester (non-sulfonated): Practical Workflow
2026-08-30
Cy3 NHS ester (non-sulfonated) provides an orange fluorescent NHS ester for labeling accessible amino groups on proteins, peptides, and amino-modified oligonucleotides. Because it is water-insoluble and requires an organic co-solvent, it is better suited to workflows that tolerate DMSO or DMF than to delicate biomolecules requiring strictly aqueous handling.
-
Cy5.5 NHS Ester for ORP Imaging
2026-08-29
Cy5.5 NHS ester (non-sulfonated) converts amine-bearing biomolecules into near-infrared imaging probes, creating a practical route for tracking polysaccharide distribution and biomolecule fate. This guide connects the extraction and gastrointestinal-distribution findings for Oudemansiella raphanipies polysaccharides with reproducible conjugation, purification, imaging, and troubleshooting workflows.
-
Mildronate Lipidoids for Lower-Inflammation mRNA Delivery
2026-08-28
The 2024 ACS Nano study developed mildronate-derived cationic lipidoids and formulated mLNP-69 to preserve effective mRNA delivery while reducing local inflammatory effects associated with conventional lipid nanoparticles. In prophylactic and therapeutic B16OVA melanoma models, this low-lipid-dose strategy supported tumor prevention or delayed progression, providing a useful framework for safer preclinical vaccine development research.
-
BRCAness and Olaparib Sensitivity in Mesothelioma
2026-08-28
Borchert et al. integrated in vitro drug-response testing with homologous recombination repair gene-expression profiling to evaluate whether BRCAness predicts olaparib sensitivity in malignant pleural mesothelioma. Their findings support particular interest in BAP1-mutated tumors and cisplatin–olaparib combinations, while the absence of clinical validation limits immediate therapeutic interpretation.
-
Neticonazole Hydrochloride: Applied Research Workflows
2026-08-27
Neticonazole Hydrochloride connects superficial Candida models with exploratory colorectal cancer research through distinct, testable assay workflows. This guide covers sample handling, fungal cell membrane synthesis inhibition, exosome-related readouts, apoptosis analysis, formulation-aware controls, and troubleshooting without conflating topical clinical use with unapproved oncology treatment.